Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Kalousová, M; Zima, T; Krane, V; März, W; Wanner, C; Tesař, V; Drechsler, C; German Diabetes and Dialysis Study Investigators.
Pregnancy-associated plasma protein A associates with cardiovascular events in diabetic hemodialysis patients.
Atherosclerosis. 2014; 236(2):263-269
Doi: 10.1016/j.atherosclerosis.2014.07.003
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- März Winfried
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Pregnancy-associated plasma protein A (PAPP-A) has prognostic impact in pregnancy and acute coronary syndrome. Patients with chronic kidney disease have an excessive cardiovascular risk. In an effort to identify novel risk factors for cardiovascular disease, we investigated the relationship of PAPP-A with specific outcomes in diabetic patients undergoing dialysis. PAPP-A was measured in 1098 diabetic hemodialysis patients, who participated in the German Diabetes and Dialysis Study and followed-up for a median of 4 years. By Cox regression analysis, we assessed the association of baseline levels of PAPP-A with all-cause mortality, combined cardiovascular events and the specific outcomes of sudden death, stroke, myocardial infarction and infectious mortality. Patients had a mean age of 66 ± 8 years (54% male) and median PAPP-A concentration of 17 mIU/L (IQR 13.4-20.9 mIU/L). Per standard deviation increase in PAPP-A the adjusted risk of sudden cardiac death increased by 23% (HR 1.23, 95%CI 1.12-1.36). Categorical analyses showed that the patients in the 4(th) PAPP-A quartile had an adjusted 2.6 fold increased risk of sudden death and 2.8 fold increased risk of stroke as compared to the patients in the 1st quartile. Similarly, the risk of combined cardiovascular events was significantly elevated by the factor 1.5 in patients of the 4(th) quartile. Additionally, PAPP-A levels were associated with infectious deaths and all-cause mortality. PAPP-A is associated with sudden death, stroke and infectious complications in diabetic dialysis patients. PAPP-A may be useful for risk assessment and monitoring in populations at high risk of cardiovascular events. Copyright © 2014 The Authors. Published by Elsevier Ireland Ltd.. All rights reserved.
- Find related publications in this database (using NLM MeSH Indexing)
- Adolescent -
- Adult -
- Aged -
- Aged, 80 and over -
- Atorvastatin -
- Cardiovascular Diseases - epidemiology
- Cause of Death -
- Comorbidity -
- Death, Sudden, Cardiac - epidemiology
- Diabetes Complications - epidemiology
- Diabetic Nephropathies - blood
- Diabetic Nephropathies - epidemiology
- Diabetic Nephropathies - therapy
- Female -
- Follow-Up Studies -
- Germany - epidemiology
- Heptanoic Acids - therapeutic use
- Humans -
- Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use
- Infection - mortality
- Kidney Failure, Chronic - blood
- Kidney Failure, Chronic - epidemiology
- Kidney Failure, Chronic - therapy
- Lipids - blood
- Male -
- Middle Aged -
- Mortality -
- Myocardial Infarction - epidemiology
- Pregnancy-Associated Plasma Protein-A - analysis
- Prognosis -
- Proportional Hazards Models -
- Prospective Studies -
- Pyrroles - therapeutic use
- Renal Dialysis -
- Risk Assessment -
- Smoking - epidemiology
- Stroke - epidemiology
- Young Adult -
- Find related publications in this database (Keywords)
- Atherosclerosis
- Cardiovascular disease
- Diabetes mellitus
- Sudden death
- Stroke